| Document Date: 2013-04-16 07:21:47
Open Document File Size: 243,59 KBShare Result on Facebook
Company Intendis GmbH / Cox / MA. Blackwells Publishing Co. / IMPRINT Blackwell Verlag GmbH / Blackwell Verlag GmbH / / / / IndustryTerm alcohol solution / intravenous applications / therapeutic site / chemical optimisation / / MarketIndex Atopic Dermatitis Severity / / MedicalCondition telangiectasia length / chronic moderate-tosevere AD / Atopic Dermatitis / telangiectasia / disease / dermatologic disease / chronic inflammatory pruritic skin disease / significantly improved disease / dermatitis / severe atopic dermatitis / eczema / inflammatory skin disorders / itching / Allergy / moderate-tosevere atopic dermatitis / atopic eczema / dissociation / / MedicalTreatment innovative therapies / / Person Stephanie Kramer / Arch Dermatol / Tobias Trinkl / / / Position Investigator / Editor / MP / / Product methylprednisolone / Prednisolone / mometasone furoate / hydrocortisone / / ProgrammingLanguage R / C / / Technology alpha / pharmacokinetics / gene expression / / URL www.blackwellpublishing.com / www.blackwell.de / /
SocialTag |
Dermatology Issue 6 t 2008 Optimised Treatment in Atopic Dermatitis – An Update and Outlook Treatment success factors – what makes a difference?